文献速递糖尿病

高胰岛素型2型糖尿病患者感染风险升高:一项丹麦12年队列研究

Elevated risk of infection in individuals with hyperinsulinaemic type 2 diabetes: a Danish 12 year cohort study.
PubMed 文献 · Diabetologia · 2024-12-11

该丹麦12年队列研究将7265例新诊断2型糖尿病患者按胰岛素敏感性和β细胞功能分为高胰岛素型、经典型和胰岛素缺乏型,随访至首次医院治疗感染或首次抗感染药物处方。高胰岛素型患者医院治疗感染10年风险为42.3%,高于经典型36.8%和胰岛素缺乏型31.0%,校正后HR为1.38。

要点

  • 高胰岛素型2型糖尿病占28%,经典型63%,胰岛素缺乏型9%。
  • 医院治疗感染10年风险:高胰岛素型42.3%、经典型36.8%、胰岛素缺乏型31.0%。
  • 与胰岛素缺乏型相比,高胰岛素型医院治疗感染校正HR为1.38(95%CI 1.16,1.65)。

核心结论

  • 以胰岛素抵抗/高胰岛素血症为特征的2型糖尿病患者严重感染风险明显升高。

研究设计与样本

  • 丹麦12年队列研究,纳入7265例新诊断2型糖尿病患者(中位病程1.4年,IQR 0.5-2.9年),按HOMA2-B和HOMA2-S分为高胰岛素型、经典型和胰岛素缺乏型,随访至首次医院治疗感染或首次抗感染药物处方,采用Cox回归分析校正年龄、性别、指数年份、糖尿病病程和治疗、生活方式行为及合并症。

主要发现

  • 高胰岛素型、经典型和胰岛素缺乏型分别占28%、63%和9%。
  • 医院治疗感染10年风险分别为高胰岛素型42.3%、经典型36.8%、胰岛素缺乏型31.0%。
  • 与胰岛素缺乏型相比,医院治疗感染校正HR:高胰岛素型1.38(95%CI 1.16,1.65),经典型1.20(95%CI 1.02,1.42)。
  • 社区治疗感染10年风险分别为高胰岛素型91.6%、经典型90.1%、胰岛素缺乏型88.3%,校正HR:高胰岛素型1.20(95%CI 1.08,1.33),经典型1.10(95%CI 1.00,1.21)。
  • 进一步校正腹部肥胖、代谢紊乱和低度炎症后,高胰岛素型亚组的感染风险大幅降低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: A better understanding of the mechanisms underlying an elevated infection risk in individuals with type 2 diabetes is needed to guide risk stratification and prevention. We investigated the risk of infection in subgroups of individuals with type 2 diabetes according to indices of insulin sensitivity and beta cell function. METHODS: We classified 7265 individuals with recently diagnosed type 2 diabetes (median duration 1.4 years, IQR 0.5-2.9 years) into hyperinsulinaemic (high beta cell function [HOMA 2-beta-cell function, HOMA2-B], low insulin sensitivity [HOMA 2-insulin sensitivity, HOMA2-S]), classical (low HOMA2-B, low HOMA2-S) and insulinopenic (low HOMA2-B, high HOMA2-S) type 2 diabetes. Individuals were followed until first hospital-treated infection or first prescription for an anti-infective agent (community-treated infection). We used Cox regression analysis to estimate HRs adjusted for age, sex, index year, diabetes duration and treatment, lifestyle behaviours and comorbidities. RESULTS: Among study participants, 28% had hyperinsulinaemic, 63% had classical and 9% had insulinopenic type 2 diabetes. The 10 year risks of hospital-treated infections were 42.3%, 36.8% and 31.0% in the three subgroups, respectively. Compared with the insulinopenic subgroup, adjusted HRs for hospital-treated infections were elevated for hyperinsulinaemic (1.38 [95% CI 1.16, 1.65]) and classical type 2 diabetes (1.20 [95% CI 1.02, 1.42]). The 10 year risks of community-treated infections were high in all three subgroups at 91.6%, 90.1% and 88.3%, respectively, corresponding to adjusted HRs of 1.20 (95% CI 1.08, 1.33) for the hyperinsulinaemic and 1.10 (95% CI 1.00, 1.21) for the classical subgroup. Infection risk in the hyperinsulinaemic subgroup decreased substantially when further adjusted for abdominal obesity, metabolic derangements and low-grade inflammation. CONCLUSIONS/INTERPRETATION: The risk of severe infections is clearly elevated in individuals with type 2 diabetes characterised by a higher degree of insulin resistance/hyperinsulinaemia.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Kristensen FPB, Domazet SL, Nielsen JS, et al. Elevated risk of infection in individuals with hyperinsulinaemic type 2 diabetes: a Danish 12 year cohort study. Diabetologia. 2024. PMID: 39663235. doi:10.1007/s00125-024-06342-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。